B upivacaine is a long-acting, lipophilic local anesthetic agent that is broadly used for cutaneous infiltration, peripheral nerve blocks, epidural anesthesia, and spinal anesthesia. Systemic toxicity from local anesthetic overdose can occur from accidental intravascular injection, drug overdose, or rapid absorption from the administration site (1). Well-described cardiotoxic effects of bupivacaine include dysrhythmias, hypotension, and depression of cardiac output leading to cardiac arrest (2).
B upivacaine is a long-acting, lipophilic local anesthetic agent that is broadly used for cutaneous infiltration, peripheral nerve blocks, epidural anesthesia, and spinal anesthesia. Systemic toxicity from local anesthetic overdose can occur from accidental intravascular injection, drug overdose, or rapid absorption from the administration site (1) . Well-described cardiotoxic effects of bupivacaine include dysrhythmias, hypotension, and depression of cardiac output leading to cardiac arrest (2) .
It has been shown by Weinberg et al (3) (4) (5) that in rat and canine models, lipid emulsion (LE) is effective in resuscitation from cardiac arrest resulting from bupivacaine overdose. Successful resuscitation of bupivacaine cardiotoxicity by LE has also been reported in patients (6) (7) (8) . In spite of the proven efficacy of LE in resuscitating bupivacaine-induced cardiac arrest, the underlying mechanism behind the interaction of LE and bupivacaine is not fully understood. Lipid sink theory was among one of the several mechanisms proposed for the rescue action that LE showed (5, 9, 10) . Based on this theory, fat droplets in the blood form lipid compartments or "lipid sinks," into which lipophilic drugs like bupivacaine might dissolve; therefore, LE increases the clearance of local anesthetic from the aqueous plasma or cardiac tissue (5) .
It was also suggested that LE might have metabolic effects since bupivacaine impairs the production of adenosine triphosphate (11) , and LE may therefore attenuate a component of cardiotoxicity resulting from bupivacaine's inhibition of adenosine triphosphate synthesis (3, 5) . In fact, the discovery of lipid rescue was based on the metabolic effects of bupivacaine on mitochondria and the role of lipid treatment (3) . The failure of LE treatment 5 mins after relatively high doses of epinephrine and vasopressin in swine model makes the metabolic mechanism more likely (1) .
Objectives: Lipid emulsion has been shown to be effective in resuscitating bupivacaine-induced cardiac arrest but its mechanism of action is not clear. Here we investigated whether fatty-acid oxidation is required for rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats. We also compared the mitochondrial function and calcium threshold for triggering of mitochondrial permeability transition pore opening in bupivacaine-induced cardiac arrest before and after resuscitation with lipid emulsion.
Design: Prospective, randomized animal study. Setting: University research laboratory. Subjects: Adult male Sprague-Dawley rats.
Interventions: Asystole was achieved with a single dose of bupivacaine (10 mg/kg over 20 secs, intravenously) and 20% lipid emulsion infusion (5 mL/kg bolus, and 0.5 mL/kg/min maintenance), and cardiac massage started immediately. The rats in CVT-4325 (CVT) group were pretreated with a single dose of fatty-acid oxidation inhibitor CVT (0.5, 0.25, 0.125, or 0.0625 mg/kg bolus intravenously) 5mins prior to inducing asystole by bupivacaine overdose. Heart rate, ejection fraction, fractional shortening, the threshold for opening of mitochondrial permeability transition pore, oxygen consumption, and membrane potential were measured. The values are mean ± sem.
Measurements and Main Results: Administration of bupivacaine resulted in asystole. Lipid Emulsion infusion improved the cardiac function gradually as the ejection fraction was fully recovered within 5 mins (ejection fraction = 64 ± 4% and fractional shortening = 36 ± 3%, n = 6) and heart rate increased to 239 ± 9 beats/min (71% recovery, n = 6) within 10 mins. Lipid emulsion was only able to rescue rats pretreated with low dose of CVT (0.0625 mg/kg; heart rate ~ 181 ± 11 beats/min at 10 mins, recovery of 56%; ejection fraction = 50 ± 1%; fractional shortening = 26 ± 0.6% at 5 mins, n = 3), but was unable to resuscitate rats pretreated with higher doses of CVT (0.5, 0.25, or 0.125 mg/kg). The calcium-retention capacity in response to Ca 2+ overload was significantly higher in cardiac mitochondria isolated from rats resuscitated with 20% lipid emulsion compared to the group that did not receive Lipid Emulsion after bupivacaine overdose (330 ± 42 nmol/mg vs. 180 ± 8.2 nmol/ mg of mitochondrial protein, p < .05, n = 3 in each group). The mitochondrial oxidative rate and membrane potential were similar in the bupivacaine group before and after resuscitation with lipid emulsion infusion.
Conclusions: Fatty-acid oxidation is required for successful rescue of bupivacaine-induced cardiotoxicity by lipid emulsion. This rescue action is associated with inhibition of mitochondrial permeability transition pore opening. (Crit Care Med 2012; 40: 2431-2437) KEY WORDS: bupivacaine; cardiotoxicity; CVT; fatty-acid oxidation; lipid emulsion; local anesthetic toxicity; mitochondrial permeability transition pore
Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats*
The role of mitochondrial permeability transition pore (mPTP) has been also highlighted in myotoxicity induced by bupivacaine overdose in skeletal muscle, as mPTP was a major underlying cause of mitochondrial depolarization induced by bupivacaine (12) . In fact, this event was shown to be essential for the subsequent dysfunction that leads to hypercontracture and cell death (12) .
Here we examined the hypothesis that the protective action of LE: (1) is mediated through fatty-acid oxidation pathway; and (2) is associated with inhibition of mPTP opening.
We used CVT-4325 (CVT), which is a piperazine derivative that is known to inhibit fatty-acid oxidation in cardiac mitochondria with a high potency in a dose-dependent manner (13) (14) (15) (16) (17) . We also compared the mitochondrial function and calcium threshold for triggering of mPTP opening in bupivacaine-induced cardiac arrest with and without resuscitation with LE infusion.
MATERIALS AND METHODS

Animals and Treatments
Adult male Sprague-Dawley rats (300-350 g) were used. Protocols have received institutional approval. Thirty-nine rats were used for this study. The technician assigned the rats randomly to different groups. Rats were anesthetized intraperitoneally with a mixture of ketamine (80 mg/kg) and xylazine (8 mg/kg). Rats were intubated via tracheotomy using a 16-gauge angiocatheter and ventilated with a ventilator. The ventilation was continued throughout the resuscitation on 100% oxygen. The femoral vein was accessed through a 22-gauge intravenous catheter. To induce asystole, the rats were treated with a single injection of bupivacaine at 10 mg/kg. This dose has been used commonly by the Weinberg group to achieve cardiac depression rapidly and decrease the variability in the time to reach asystole (18) (19) (20) . The dose of LE used in this study to resuscitate the rats from bupivacaine-induced cardiotoxicity is also similar to that used by the Weinberg group (one bolus of 5 mL/kg, and 0.5 mL/kg/min for maintenance (18, 20) ). Some rats were pretreated with a single bolus of fatty-acid oxidation inhibitor CVT at different doses (0.5, 0.25, 0.125, or 0.0625 mg/kg bolus intravenously). Body temperature was maintained at 37°C throughout the experiment. The rats which were resuscitated by LE were euthanized at the end of the experiments by quickly removing the heart before recovery from anesthesia according to the protocol approved by the UCLA institutional review board and committee. The investigator injecting the medications was not blinded, but those performing the echocardiography or those isolating mitochondria were blinded.
Experimental Protocols
Blocking of Fatty-acid Oxidation. Rats were randomly divided in two groups of control (CTRL) and CVT ( Fig. 1A ). In the control group (n = 6 rats), after measuring the heart rate (HR) and ejection fraction (EF) at the baseline, asystole was achieved with a single dose of bupivacaine (10 mg/kg over 20 secs, intravenously). The infusion of LE (20% intralipid [Sigma, St. Louis, MO], 5 mL/kg bolus, and 0.5 mL/kg/ min maintenance) with cardiac massage was started immediately. In the CVT group, the HR and EF were measured 5 mins before and after a single bolus of fatty-acid oxidation inhibitor CVT at different doses (0.5, 0.25, 0.125, or 0.0625 mg/kg bolus intravenously, n = 3 rats per each dose of CVT). The asystole was then induced by bupivacaine overdose, and LE infusion (20% intralipid [Sigma], 5 mL/kg bolus, and 0.5 mL/kg/min maintenance) along with cardiac massage was started immediately.
Mitochondrial Functional Measure ments. Rats were randomly divided in three groups. The mitochondria were isolated from: 1) CTRL group, in which rats were only treated with a single injection of phosphate buffered saline (PBS); 2) Bup group, rats were treated with a single injection of bupivacaine (10 mg/ kg over 20 secs) to induce asystole; and 3) LE group, after inducing asystole with bupivacaine overdose, rats were resuscitated with LE (20%, 5 mL/kg bolus, and 0.5 mL/kg/min for maintenance) along with cardiac massage for 10 mins. Rats were euthanized within 2 mins of PBS/Bup infusion in group 1 and 2 (this is the time that usually takes for the heart to go to asystole after Bup infusion) and 10 mins after LE infusion in group 3 as indicated by the arrowhead (Fig. 1 ). The isolation of mitochondria was started immediately only from the left ventricle. The freshly isolated mitochondria were used for measuring oxygen consumption (n = 3 in CTRL, n = 3 in LE, and n = 4 in Bup), membrane potential (n = 3 in CTRL, n = 3 in LE and n = 4 in Bup), and calcium-retention capacity (CRC) in response to Ca 2+ overload (n = 4 in LE and n = 4 in Bup).
Mitochondrial Isolation
Mitochondria were isolated only from the left ventricle as described previously (18) . Briefly, left ventricular myocardial sections of approximately 0.15-0.22 g were placed in isolation buffer A containing mM 70 sucrose, 210 mannitol, 1 EDTA, and 50 Tris-HCl, pH 7.4 at 4°C. The tissue was finely minced with Figure 1. Experimental protocols. A, In the control (CTRL) group, asystole was achieved by a single injection of bupivacaine (Bup) (10 mg/kg over 20 secs) and resuscitation with lipid emulsion (LE) (5 mL/kg bolus, and 0.5 mL/kg/min maintenance) together with cardiac massage was started immediately (n = 6 rats). In the CVT-4325 (CVT) group, the experimental protocol was identical to CTRL group, except that the rats were pretreated with different doses of CVT-4325 (0.5, 0.25, 0.125, 0.0625 mg/kg) for 5 mins (n = 3 rats/each dose of CVT). B, The mitochondria were isolated from three groups: (1) CTRL group, rats only received a single injection of phosphate buffered saline (PBS); (2) Bup group, rats only received a single injection of Bup (10 mg/kg over 20 secs) to induce asystole, and (3) LE group, after inducing asystole with Bup overdose, rats were resuscitated with 20% LE (5 mL/kg bolus, and 0.5 mL/kg/min maintenance). Rats were euthanized in all three groups at the time indicated with arrowhead (within 2 mins of PBS/Bup infusion in groups 1 and 2 and 10 mins after LE infusion in group 3 as indicated with arrowhead and the mitochondria were isolated immediately only from left ventricle. The mitochondria were used for measuring calcium-retention capacity (in response to Ca 2+ overload), oxygen consumption, and membrane potential. scissors and homogenized in the same buffer A (1 mL buffer/0.1 g of tissue) using Kontes and Potter-Elvehjem tissue grinders. The homogenate was centrifuged at 1300g for 3 mins, the supernatant was filtered through a cheesecloth and centrifuged at 10,000g for 10 mins. The mitochondrial pellet was resuspended in isolation buffer B containing mM 70 sucrose, 210 mannitol, 0.1 EDTA, and 50 Tris-HCl, pH 7.4. Mitochondrial protein concentration was measured using the Bradford assay. The freshly isolated mitochondria were used for measuring CRC in response to Ca 2+ overload, oxygen consumption, and membrane potential. The investigator isolating the mitochondria was blinded to the protocol.
Measurement of Mitochondrial Respiration
Mitochondrial respiration was measured using a fiber optic oxygen sensor FOXY-AL300 (Ocean Optics, Dunedin, FL) in a partially open continuously stirred cuvette at 25°C as reported (21) . Freshly isolated mitochondria were suspended in KCl, Mops, and EGTA buffer (100 mM KCl, 50 mM Mops, 0.5 mM EGTA), and mitochondrial concentration was measured. Isolated mitochondria (500 μg) were added to the assay buffer containing 125 mmol/L KCl, 10 mmol/L Hepes, potassium phosphate (Pi, 2.5 mmol/L), pH 7.4 with Tris. To measure complex I-mediated respiration rates, substrates combinations of 1.6 mmol/L pyruvate plus 1.6 mmol/L L-malate and 1.6 mmol/L glutamate were added to the mitochondria. The respiration values in state 3 (stimulated by 0.2 mM adenosine diphosphate [ADP]) and state 4 (ADP-limited) were measured. The Respiratory Control Ratio was measured by dividing the respiratory values in state 3 to state 4, and were normalized to milligrams of mitochondrial protein.
Determination of Mitochondrial Membrane Potential
Determination of mitochondrial membrane potential was monitored by transmembrane distribution of the fluorescence indicator tetramethylrhodamine methyl ester according to the Nernst equation (22) . Briefly, 500 μg freshly isolated cardiac mitochondria were suspended in 2 mL of the respiration buffer containing 200 nM tetramethylrhodamine methyl ester, and the fluorescence was recorded at 25°C at excitation and emission wavelengths of 550 nm and 580 nm, respectively. After the equilibration period to reach state 2 (1.6 mM pyruvate/malate/glutamate added, without ADP), state-3 respiration was evoked by the addition of 200 μM ADP. Mitochondrial membrane potential was assessed by comparing the fluorescence before and after addition of 2-μM alamethacin, a mitochondrial uncoupler that fully depolarizes mitochondria.
Measurement of Mitochondrial CRC
The onset of the mPTP opening was assessed in freshly isolated mitochondria following in vitro Ca 2+ overload. Free Ca 2+ concentration outside the mitochondria was recorded with 0.5 µM calcium green-5N (Invitrogen, Grand Island, NY) using excitation and emission wavelengths set at 500 nm and 530 nm, respectively. Isolated mitochondria (1 mg of protein) were suspended in 2 mL buffer C (mM, 150 sucrose, 50 KCl, 2 KH 2 PO 4 , 5 succinic acid, and 20 Tris/HCl, pH 7.4). Samples were preincubated for 90 secs in the spectrofluorometer cuvette, and Ca 2+ pulses (20 nmol/mg of mitochondrial protein) were applied every 60 secs in the spectrofluorometer. The Ca 2+ pulses induced a peak of extra-mitochondrial Ca 2+ concentration that returned to near-baseline level as Ca 2+ entered the mitochondrial matrix via the Ca 2+ uniporter. With increasing Ca 2+ loading, the extra-mitochondrial Ca 2+ concentration started accumulating, reflecting a lower capacity for mitochondria Ca 2+ uptake, which was followed by a sustained Ca 2+ increase indicating a massive release of the mitochondria Ca 2+ by the mPTP opening. The CRC was defined as the amount of Ca 2+ required to trigger this massive Ca 2+ release, which was used here as an indicator of the mPTP sensitivity to Ca 2+ . CRC was expressed as nmol of CaCl 2 per mg of mitochondrial protein.
Cardiac Hemodyanamics
Serial B-Mode and M-Mode echocardiography was performed at baseline and at 1, 5, and 10 mins after LE treatment to measure the EF and fractional shortening using a VisualSonics Vevo 770 (VisualSonics, Toronto, Canada) equipped with a 30-MHz linear transducer. The electrocardiogram was monitored and acquired through standard lead II, under anesthesia continuously throughout the experiment. The investigator performing the echocardiography was blinded to the protocol.
Statistics
For HR, EF, fractional shortening, means were compared between group and over time using a repeated measure analysis of variance model. The individual pairwise mean comparisons were evaluated using the (Tukey, Fisher's least significant difference) criterion to adjust for multiple comparisons. For CRC (mPTP opening) and membrane potential measurements, means were compared between LE vs. bupivacaine using t tests. For mitochondrial respiration, means were compared across the three groups of CTRL, bupivacaine, and LE using one-way analysis of variance. p values < .05 were considered statistically significant. Means and standard error of the mean (mean ± sem) are reported. The error bars in the figures are based on the sem.
RESULTS
The Role of Fatty-acid Oxidation in Reversal of Bupivacaine-induced Cardiotoxicity by LE. To examine whether rescue of bupivacaine-induced cardiac arrest by LE is mediated via fatty-acid oxidation pathway, we used CVT-4325, which is a piperazine derivative that inhibits fattyacid oxidation in cardiac mitochondria with a high potency (13) (14) (15) (16) (17) . M-mode echocardiography images in Figure 2A from the same rat shows gradual resuscitation from bupivacaine-induced cardiotoxicity by LE in the CTRL group (Fig.1A for experimental protocol). However, in the rats pretreated with CVT doses of 0.125 mg/kg or higher, LE was not able to rescue the rat and only partial recovery was observed in the presence of lower CVT dose (0.0625 mg/kg, Fig. 2A) . The HR and EF at baseline in CTRL group before application of bupivacaine were 336.7 ± 12.1 and 72.7 ± 1.3%, respectively ( Fig. 2  B and C) . Administration of bupivacaine resulted in asystole as expected, and 20% LE resuscitation improved HR and cardiac function gradually within 10 mins. The HR was, 74.7 ± 4.6 beats/min at 1 min (22% recovery), increased to 197.5 ± 13.2 beats/min at 5 mins (59% recovery), and further to 239 ± 9.5 beats/min 10 mins after the initiation of LE therapy (71% recovery). The left ventricular systolic function was fully recovered in all rats within 5 mins of LE treatment (EF = 64 ± 4%, fractional shortening = 36 ± 3%, Fig. 2C and D) .
In CVT groups, the baseline HR and EF were similar before and 5 mins after different doses of CVT (e.g., at 0.5 mg/kg, HR [beats/min] = 316.7 ± 8.8 vs. 311.7 ± 12, 5 mins after CVT; EF = 74.7 ± 3.5% vs. 74.1 ± 4.9%, 5 mins after CVT), indicating that CVT-4325 alone does not affect the HR or the cardiac function at all different doses of CVT. However, CVT pretreatment at higher doses of 0.5, 0.25, or 0.125 mg/kg (CVT-high) prevented the lipid rescue of bupivacaine overdose, as there was no recovery of cardiac function within 10 mins of LE therapy. Resuscitation with 20% LE was only able to rescue bupivacaineinduced cardiotoxicity at the lowest dose of 0.0625 mg/kg CVT (CVT-low) as cardiac function improved gradually within 10 mins (HR from 71 ± 5 at 1 min increased to 181 ± 11 mins at 10 mins; EF = 50 ± 1%; fractional shortening = 26 ± 0.6% at 5 mins, and QRS from 33 msecs at 1 min to 27 msecs at 10 mins).
The Effect of LE on Mitochondrial Oxidative Rate and Membrane Potential.
We compared the oxidative rates in cardiac mitochondria isolated from the hearts of CTRL, Bup and LE groups (see Figure  1B for experimental protocol). The visual inspection of oxygen electrode traces in isolated cardiac mitochondria from these three groups revealed similar slopes in state 3 (ADP-stimulated) and state 4 (resting state, ADP-limited, Fig. 3A) . The slope of the state-3 and state-4 respiration values in cardiac mitochondria isolated from CTRL rats that were only treated with a single dose of PBS were 112 ± 4.8 and 23 ± 6.5 nmol O/min/mg protein, respectively which resulted in a respiratory control ratio value of 5.6 ± 1.2 ( Fig. 3 B  and C) Fig. 3B ). As a result, respiratory control ratio values in the Bup group (4.9 ± 0.5), the LE group (4.6 ± 0.8, Fig. 3C ) and the CTRL group were indistinguishable (p > .05 vs. CTRL for both Bup and LE groups). LE also had no apparent effect on the mitochondrial membrane potential as the change in fluorescence intensity before and after the addition of the uncoupler in the LE group was not significantly different from that in the Bup or CTRL groups (0.85 ± 0.07 in LE vs. 0.96 ± 0.04 in Bup and 1 ± 0.07 in CTRL, p > .05 vs. CTRL for both Bup and LE groups, Fig. 3 D and E) .
The Effect of LE on mPTP Opening. Next, we compared the threshold for triggering of mPTP openings in response to calcium overload in isolated mitochondria from the hearts of Bup and LE groups (see Fig. 1B for experimental protocol). Figure 4A shows a typical example of the time course of Ca 2+ concentration in the mitochondrial external medium. In bup group, nine pulses of 20 nmol Ca 2+ were sufficient to trigger the opening of mPTP. Interestingly, the calcium load required for triggering mPTP opening significantly increased in mitochondria isolated from LE group as the number of calcium pulses (20 nmol) was increased to 17 pulses. The bar plot in Figure 4B summarizes the CRC; CRC was significantly higher in the LE group compared to bup group (330 ± 42 in LE vs. 180 ± 8.2 nmol /mg of mitochondrial protein in bup, p < .05).
DISCUSSION
It has been demonstrated previously that LE is very effective in resuscitation from cardiac arrest that results from bupivacaine toxicity in rat and canine models as well as in patients 3-8. However, the molecular mechanisms of this rescue action of LE are not fully understood. Here we show that fatty-acid oxidation is required for the successful rescue of bupivacaine-induced cardiotoxicity by LE in rats. We also show that lipid infusion is associated with inhibition of mPTP opening, without affecting mitochondrial respiration or membrane potential.
Fatty-acid Oxidation Is Required for the Successful Rescue of Bupivacaineinduced Cardiotoxicity by LE. One of the dreaded complications of local anesthetics' use in regional anesthesia is cardiovascular toxicity. Although systemic toxic reactions are not common, they can be life-threatening and resistant to treatment (23) . Local anesthetics exert their toxic effects through a complex cellular mechanism, and the ability of local anesthetics to interfere with multiple cellular functions may be the factor that makes overdose with these drugs potentially severe and refractory (23) . Treatment of systemic toxicity due to local anesthetic includes airway management and circulatory support. Local-anesthetic-induced cardiac arrest requires rapid restoration of coronary perfusion pressure to improve myocardial contractility, and maintenance of cardiac output and oxygen delivery to tissues is critical for the prevention and treatment of acidosis (24) , but still the outcome is generally poor. In two case reports of patients surviving bupivacaine-induced cardiac arrest, circulation was supported by placing the patient on cardiopulmonary bypass until spontaneous circulation recurred (7) . In 1997, investigations by Weinberg et al (3) (4) (5) led to the discovery that pretreatment with a lipid infusion increased the dose of bupivacaine required to induce asystole in rats. Further studies showed that early administration of lipid in bupivacaine-induced cardiotoxicity rescues circulatory collapse.
In 2010, American Society of Regional Anesthesia Practice Advisory on local anesthetic systemic toxicity recommended that LE therapy is instrumental in facilitating resuscitation (24) . Although more than a decade has elapsed since the findings of Weinberg et al, there are still several unanswered questions regarding LE therapy and its mechanism of action (24) . Although the lipid sink theory or "partition effect" was among one of the initial mechanisms of LE that was considered effective in the reversal of local anesthetic cardiotoxicity (5, 9, 10) , other mechanisms, including a possible metabolic benefit, have also been postulated (3, 5) .
Here we present compelling data in support of a metabolic mechanism highlighting the view that fatty-acid oxidation pathway is an important pathway in the reversal of bupivacaine cardiotoxicity by LE. LE was only able to resuscitate cardiotoxicity that resulted from bupivacaine overdose in rats pretreated with very low doses of CVT (0.0625 mg/kg). Lipid resuscitation failed if the rats were pretreated with CVT at doses higher than 0.0625 mg/kg.
Although our data provides clear evidence in support of the metabolic theory, it does not exclude other suggested mechanisms postulated previously, such as the lipid sink theory (3). Since the time course of myocardial apoptosis seems too long to account for the sudden fatal effects of bupivacaine toxicity, we speculate the rapid inhibitory action of bupivacaine on the sodium channel also play a role in inducing asystole. In this case, LE may also reverse acute effects of bupivacaine toxicity, by displacing bupivacaine from the sodium channel to rescue the cardiac arrest.
The Oxidative Rate and Membrane Potential of Mitochondria Were Similar in Cardiac Arrest Before and After Lipid Resuscitation. Highly lipophilic local anesthetics also interfere with mitochondrial energy metabolism. These metabolic effects could in part explain some of the toxic effects of local anesthetics, such as bu-pivacaine-induced myocardial depression. Indeed, some studies suggest that bupivacaine-induced cardiotoxicity may be the result of the interference with mitochondrial energy transduction (25) (26) (27) (28) (29) . In this study we show that lipid resuscitation from lipophilic drug overdose is not associated with alteration in mitochondrial oxidative rate or membrane potential. The basal and ADP-stimulated rates of respiration in the mitochondria isolated from the hearts resuscitated with LE were not significantly different from those of mitochondria prepared from bupivacaine-overdosed hearts or from CTRL hearts perfused with PBS only (Fig. 3 A-C). Since LE infusion had no effect on the mitochondrial respiration challenged by bupivacaine, the reversal of bupivacaine-induced cardiotoxicity by LE does not seem to act through stimulation of mitochondrial respiration.
Our finding is in contrast with the observations of increased oxidative rates in skeletal muscle mitochondria following incubation with bupivacaine in vitro with doses up to 1.5 mM (12) . Whether the action of bupivacaine on the mitochondria isolated from skeletal muscle is different than the heart, or our in vivo dose of 10 mg/kg bupivacaine is not comparable with the in vitro dose used for skeletal muscle, remains to be seen in future studies.
Rescue of Bupivacaine-induced Cardio toxicity by LE is Associated With Inhibition of mPTP Opening. mPTP is a large nonselective conductance pore located in the inner membrane of mitochondria. The role of mPTP in the heart has been well studied in ischemia/reperfusion setting (see review in [30] ). mPTP has been shown to remain closed during ischemia, but opens during the reperfusion period (31, 32) . The opening of mPTP at reperfusion has been implicated in cell death (33, 34) . mPTP opening has also been shown to be a major underlying cause of mitochondrial depolarization induced by bupivacaine leading to hypercontracture and cell death in isolated flexor digitorum brevis fibers (12) . Delaying the opening of the mPTP has been a potential target to reduce myocardial injury upon reperfusion. Here we show that the rescue of cardiac arrest by LE is associated with inhibition of the mPTP opening, as the mitochondrial calcium uptake required for the opening of the mPTP was significantly higher in hearts resuscitated by LE compared to the that of bupivacaine-overdosed hearts (Fig. 4) . The lower Ca 2+ threshold for triggering mPTP opening in the bupivacaine group was not due to the lower quality of the mitochondrial preparation in this group, as the respiratory control ratio in both Bup and LE groups was >4 ( Fig. 3 A-C (35, 36) ). Our results highlight the role of mPTP in the reversal of cardiotoxicity by LE. We propose that LE enhances the homeostasis of cardiomyocytes to better regulate calcium overload and therefore increase the threshold for opening of the mPTP. Although LE increases the threshold of opening of mPTP, it has no effect on mitochondria respiration or membrane potential. This is often not the case in mitochondria isolated from the hearts that are subjected to ischemia/reperfusion since the higher CRC is usually associated with higher oxidative phosphorylation and membrane potential (37) . Figure 5 summarizes our hypothetical scheme demonstrating the involvement of fatty-acid oxidation and calcium homeostasis in the rescue of bupivacaineinduced cardiotoxicity by LE in rats.
Limitations
In our study we show that the rescue of bupivacaine-induced cardiotoxicity by LE is associated with inhibition of mPTP opening. The higher threshold for triggering mPTP opening could result from a reduced tissue bupivacaine content e.g., as might occur due to the lipid sink effect. Alternately, increased mPTP activation could merely serve as an indicator of irreparable myocardial damage secondary to the cardiac arrest and resulting hypoperfusion with ischemia/reperfusion injury. Further experiments are required to demonstrate a causal relationship for the inhibition of mPTP and lipid resuscitation.
Here, using a fatty-acid oxidation inhibitor we present compelling data in support of a metabolic mechanism for the phenomenon of lipid resuscitation from bupivacaine drug overdose. There are also several case reports indicating that LE can reverse signs and symptoms of central nervous system (CNS) toxicity (38, 39) . The mechanisms by which LE reverses bupivacaine-induced toxicity in the heart may be different than the reversal mechanisms of LE in the CNS. Obviously a metabolic effect cannot contribute to the reversal of toxicity in an organ that does not require fatty-acid oxidation. As discussed in some cases of CNS toxicity following bupivacaine overdose (38, 39) , the CNS symptoms could be short-lived and self limiting and it is not clear whether the recovery from CNS toxicity is related to the lipid treatment or not. Our study has only focused on the cardiotoxicity reversal, and at present we cannot explain the reversal of CNS toxicity by LE. Additional experiments in the future could unravel the mechanisms underlying the reversal of CNS toxicity by LE.
Failure of the study to accurately mimic the in vivo pharmacokinetics of clinical bupivacaine toxicity and lipid infusion in humans is another limitation. In case reports, both the bupivacaine dose that caused cardiotoxicity as well as the LE dose used for rescue (1.5 mL/kg vs. 5 mL/kg) are lower than the dose in our rat study (24) . In the clinical situation, however, the lipid infusion is not started right away and there is a lag by the time that the infusion is available and started. We have to consider that in our study rats are already intubated and ventilated with 100% oxygen; this is different than human cases where bupivacaine toxicity appears while the patient is awake or mildly sedated and the airway Figure 5 . Proposed mechanisms underlying lipid emulsion (LE)-induced rescue of cardiac arrest as a result of bupivacaine-overdose. Oxidation of LE containing long-chain fatty-acids occurs in the mitochondria. Fatty-acids are transported into the mitochondria via carnitine shuttle, and go through ß-oxidation to produce NADH and FADH 2 . NADH and FADH 2 enter the electron-transport chain, which couples electron transfer between an electron donor (NADH and FADH 2 ) and an electron acceptor (such as O 2 ) to the transfer of H + ions (protons) across a membrane. The resulting electrochemical proton gradient is used to generate energy in the form of adenosine triphosphate (ATP) in complex V. The release of H + from complex I, III and IV leads to lowering PH in outer mitochondrial membrane, which leads to inhibition of mitochondrial permeability transition pore (mPTP) opening. Inhibition of ß-oxidation pathway by CVT abolishes the production of NADH, FADH 2 , as well as H + ions, leading to generation of less ATP. The rise of Ca 2+ ions in mitochondria through Ca 2+ uniporter will trigger the opening of mPTP. LE enhances the homeostasis of cardiomyocytes to better regulate calcium overload and therefore delay the opening of mPTP. FACS; fatty acyl CoA synthase, CPT1; carnitine acyl transferase 1, CT; carnitine acylcarnitine translocase, CPT2; carnitine acyl transferase 2.
is not controlled at the time that toxicity appears.
CONCLUSIONS
We show here that fatty-acid oxidation is required for the resuscitation of bupivacaine overdose by LE. Furthermore, the rescue of bupivacaine-induced cardiotoxicity by LE is associated with the inhibition of mPTP opening independent of oxidative phosphorylation and membrane potential. Further research is needed to identify the exact role of LE in the rescue of bupivacaine-induced cardiotoxicity.
